Manufacturing Today Issue 210 Issue 210 March 2023 | Page 162

manufacturing plant within the Novartis campus , which has enabled us to continue providing patients with these treatments in exactly the same way as before .”
Improving lives
Although the business is experiencing growth and success with its recent acquisitions , it hasn ’ t necessarily been an easy ride . “ Following the extremely difficult global events of COVID-19 and the war in Ukraine , the healthcare and pharmaceutical industries are experiencing a challenging and ever-changing environment ,” states Roberto . “ The behavior and attitude from patients , healthcare providers , and customers changed during the pandemic . Then , the outbreak of war in Ukraine consolidated these changed attitudes , as well as having a huge impact on our supply chain .
“ The pandemic caused a scarcity of products , components , and specific materials for a long period , which forced all health and pharmaceutical companies , not just Recordati , to adapt themselves and independently manage the production supply chain ,” he continues . “ We were extremely proactive and came up with clever , creative ways to manage production , as our major priority is to ensure patients can always get the products they need , available in good time , and with the high-quality standards they are accustomed to .”
162